French campaigners have secured legal action and compensation has been awareded in Court for Depakine Valproate birth defects.
Swiss campaigners are pursuing legal action against Sanofi. ASSAC is an organisation set up to support Swiss vicitms.
Belgian families are supporting each other and will also be pursuing justice.
The French regulator referred Valproate to the European Medicines Agency PRAC to assess the effectiveness of the warnings issued in 2015.
A Public Hearing was held at The EMA offices in London and was attended by those affected from UK, Eire, France, Belgium and Switzerland.
There was a lot of media coverage search #EMAPublicHearing and #valproate for links to news items and comment.
Ian McLachlan has a Youtube channel where media updates are uploaded.
In the UK the Ministry for Justice suggest families apply for Legal Aid funding.
FACSaware sent letters to top UK law firms requesting representation but none were prepared or willing to represent.
Successful lobbying by FACSaware got a Public Inquiriy into medicine and devices regulation and licensing into the 2017 Labour Party Manifesto.
UK #pharmaharm campaigns are seeking justice and recompense.
Please search #Primodos #Mesh #Contaminatedblood #Metalhips #Valproate #HPVvaccine.
We need your support so please share retweet and comment.
HPV vaccine campaigners are hoping to get a thorough review of the vaccine to establish the effectiveness and potential adverse drug reactions.
Norman Lamb MP has an APPG into AEDs in Pregnancy, it will be meeting in January 2018 at the Department of Health to discuss Valproate. At a meeting in December 2017 a Care plan and compensation package was discussed but neither agreed or disagreed.
FACSaware have submitted a report to the APPG. Report available by request please email email@example.com or visit the FACSaware facebook group.
13th December 2016
Compensation for French vicitms
A press conference was held in Paris by APESAC. They announced they would be pursuing legal action against Sanofi for Depakine birth defects.
The French government have already committed to compensating French victims.
8th February 2016
Over the last year Charities, campaign groups, professional bodies and the MHRA have worked together to develop information to raise awareness of Valproate risk.
3rd February 2016
#FACSaware and MHRA Yellow Card joined together to promote Yellow Card and Valproate risk.
29th January 2016
Stakeholder engagement meeting at MHRA
8th January 2016
Stakeholder engagement meeting at MHRA
Summary of 2015 action
FACSaware worked with the MHRA and Department of Health to develop new guidelines and information about Valproate.
NHS Choices information
The DoH Social care blog
drug safety update
Black Triangle :
A dear doctor letter.
Healthcare professional information
Patient Information Leaflet
21st November 2014
13th November 2014
FACSaware attend Department of Health
The meeting was to discuss what information needs to be given to Patients, by who and in what format.
27th June 2014
Patient participation at EMA.
#FACSaware campaigners from UK will be participating in the European Medicine Agency review into Sodium Valproate. French and Belgian campaigners will also be attending.
18th June 2014
Meeting in Parliament
Alec Shelbrooke MP, Chair of the APPG Thalidomide and other harmful drugs prescribed during pregnancy, has added Sodium Valproate birth defects to the APPG. This meeting plans to formulate a workable strategy to raise awareness of FACS. #FACSaware campaigners will be participating.
20th May 2014
International Clinical Trials Day
'This has to be the last International Clinical Trials Day of the era when trial results are withheld'
Sense about Science
Many thanks to the MHRA.
19th November 2013
We have made a difference.
#facsaware would like to thank everyone who has contributed.
18th November 2013
Sodium Valproate - The Cost.
Preview of film at the London College of Communication.
The film is a critique of the UK legal system and the cost of Sodium Valproate to the Taxpayer.
4 Mothers and 2 children attended the preview.
11th November 2013
Alec Shelbrooke MP asked questions in parliament.
Clinical Trial Transparency. The consultation currently occurring in Europe regarding the registry and publication of Clinical Trials.
Medical Records. The use of the Clinical Practice Research Datalink Group to assess Anti Epilepsy Drugs (AEDs) and whether there is a biological link between parents notes and their biological offspring notes to enable observational research into teratogens and products that may affect sperm.
4th November 2013
Dr Ian Hudson, Chief Executive of the MHRA confirmed that Sarah Morgan from the Vigilence and Risk management team at the MHRA will be aiding the European review into the use of Sodium Valproate and will keep the Department of Health up to date with progress.
29th October 2013
The meeting with Health Minister Norman Lamb MP was rescheduled.
Branwen Mann attended representing FACSAWARE with Deborah Mann. Susan Cole attended on behalf of OACS. Emma Friedmann attended on behalf of FACT. Ian McLachlan a campaigner from Scotland travelled from Glasgow. InFact and Facsa were also represented.
The Department of Health is now aware of our concerns and Claire Phillips from the Department of Health is collating information. From 2017 the responsible Minister is Lord O'Shaughnessy.
Anas Sarwar MP and Alec Shelbrooke MP were also in attendance.
16th October 2013
MHRA confirm there will be a warning in the November issue of Drug Safety Update to remind clinicans and prescribers to check current prescribing guidelines. Hopefully this will include specific warnings about the use of Sodium Valproate in women of childbearing potential.
14th October 2013
The MHRA request the European Medicines Agency review the use of Sodium Valproate.
29th September 2013
Emma Friedmann met Alec Shelbrooke MP to discuss FACS. Parents also took part in the NHS Demonstration.
24th September 2013
The MHRA contacted Emma Friedmann to confirm they will be seeking advice from experts on the use of Sodium Valproate with the view to issue further regulation if required.
MHRA also confirm the warning in the Epilim patient information leaflet about Male Infertility relates to 'reversible testicular changes and an increased number of abnormal sperm in some rats exposed to sodium valproate'.
3rd September 2013
Norman Lamb MP had invited representatives of FACT and FACSAWARE to parliament to discuss our concerns. He cancelled with less than 24 hours notice. A meeting was held in Portcullis House that was attended by read more
+AllTrials Donate Here
If medical trials were registered and published, conditions caused by pharmaceutical products would be better understood and new products without the negative side effects could be developed.
Have you been affected by Dexamethasone, DEX, Corticosteroid?
You can reach us on:
UK: 0116 2200486
Other: +44 116 2200486
Chat on Facebook
Follow us on Twitter: @facsaware
You can also use our
Email the editor:
28 Myrtle Road
I, Emma Friedmann set this up as a project for the Fetal Anti Convulsant Trust. The Trust is not currently operational due to a lack of experienced Trustees. FACSaware is an awareness campaign.
FACT will not share your details.
FACT will use your email address for email purposes only and will not keep any personal information on file.
FACT agreed we needed a global network for teratogen awareness.
I personally pay for the internet connection, maintenance of hardware and hosting service.
Everything else is free and done voluntarily with only reputation at stake.
facsaware.net does not have a bank account.
facsaware.net is not a registered charity.
facsaware.net is not an incorporated or unincorporated organisation.
Financial contributions offered to facsaware.net will be declined unless specifically granted to cover expenses.
Contributors to this site agree to unlimited distribution of their information.
I cannot guarantee the content, practices and ethics of external websites.